Muma N A, Cork L C
Department of Pathology, School of Hygiene and Public Health, Baltimore, Maryland.
Lab Invest. 1993 Oct;69(4):436-42.
Hereditary canine spinal muscular atrophy (HCSMA) is a dominantly inherited motor neuron disease in which distal axonal caliber is reduced in lower motor neurons. Because several animal models show that neurofilament protein gene expression is a major determinant of axonal caliber, we began an examination of neurofilament gene expression in HCSMA early in the clinical disease to determine whether this family of proteins was selectively affected and could thus possibly contribute to the morphologic and functional alterations characteristic of the disease.
We used quantitative in situ hybridization to compare levels of mRNA encoding neurofilament protein subunits in lateral ventral horn neurons from the cervical spinal cord enlargement (C7-C8) in 10-week-old homozygous HCSMA and control dogs. Each slide contained a spinal cord section from a control and an HCSMA dog in order to make within-slide comparisons. The mean number of grains/neuron and the mean neuronal grain density for the HCSMA section were divided by that value for the control section on each slide. The means of these ratios for each mRNA species (i.e., neurofilament subunits and total polyadenylated mRNA (poly-A+) were then compared statistically.
The levels of mRNA encoding the low molecular weight neurofilament protein subunit were significantly different from levels of mRNA encoding the high molecular weight neurofilament protein subunit and poly-A+ mRNA in dogs with HCSMA compared with control dogs. The neuronal levels of poly-A+ mRNA were comparable in dogs with HCSMA and controls.
If neurofilament protein subunit levels are found to follow the mRNA levels in this animal model, our results would suggest that decreased expression of the low molecular weight neurofilament gene is sufficient to inhibit neurofilament function, i.e., maintenance of axonal caliber, probably by disrupting normal neurofilament assembly.
遗传性犬脊髓性肌萎缩症(HCSMA)是一种显性遗传的运动神经元疾病,其中下运动神经元的远端轴突直径减小。由于几种动物模型表明神经丝蛋白基因表达是轴突直径的主要决定因素,我们在临床疾病早期开始研究HCSMA中的神经丝基因表达,以确定这一族蛋白质是否受到选择性影响,从而可能导致该疾病特有的形态和功能改变。
我们使用定量原位杂交技术,比较10周龄纯合HCSMA犬和对照犬颈髓膨大(C7 - C8)侧腹角神经元中编码神经丝蛋白亚基的mRNA水平。每张载玻片包含来自一只对照犬和一只HCSMA犬的脊髓切片,以便进行片内比较。将HCSMA切片的每个神经元的平均颗粒数和平均神经元颗粒密度除以每张载玻片上对照切片的该值。然后对每种mRNA种类(即神经丝亚基和总聚腺苷酸化mRNA(poly - A +))的这些比率的平均值进行统计学比较。
与对照犬相比,患有HCSMA的犬中编码低分子量神经丝蛋白亚基的mRNA水平与编码高分子量神经丝蛋白亚基和poly - A + mRNA的水平有显著差异。患有HCSMA的犬和对照犬的神经元中poly - A + mRNA水平相当。
如果在这个动物模型中发现神经丝蛋白亚基水平与mRNA水平一致,我们的结果将表明低分子量神经丝基因表达的降低足以抑制神经丝功能,即维持轴突直径,可能是通过破坏正常的神经丝组装。